Maze Therapeutics, Inc.
MAZE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $317 | $265 | $294 | $197 |
| Short-Term Investments | $67 | $0 | $0 | $0 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $7 | $5 | $5 |
| Total Curr. Assets | $391 | $271 | $300 | $202 |
| Property Plant & Equip (Net) | $26 | $28 | $29 | $30 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $4 | $3 | $8 |
| Total NC Assets | $31 | $32 | $33 | $39 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $422 | $304 | $333 | $241 |
| Liabilities | – | – | – | – |
| Payables | $3 | $4 | $2 | $2 |
| Short-Term Debt | $5 | $5 | $5 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $12 | $12 | $14 |
| Total Curr. Liab. | $22 | $20 | $19 | $21 |
| LT Debt | $19 | $20 | $21 | $22 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $21 | $21 | $22 | $23 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $24 | $25 | $26 | $27 |
| Total Liabilities | $43 | $41 | $41 | $44 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $508 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$455 | -$425 | -$391 | -$358 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $834 | $687 | $683 | $47 |
| Total Equity | $379 | $262 | $292 | $197 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $422 | $304 | $333 | $241 |
| Net Debt | -$293 | -$240 | -$269 | -$170 |